Founded in 1968 as Lupin Laboratories Ltd, is one of the largest Pharmaceuticals Indian industry. It is located in Mumbai (Maharashtra) India.
In 1989, the company installed a JV by the name of Lupin Chemicals (Thailand). In 2001, Lupin Labs and Lupin Chemicals mixed to form Lupin Ltd. Lupin industry APIs, finished dosages, and herbal products. Lupin’s range of produced important drugs includes anti-tuberculosis drugs, cephalosporin, cardiovascular drugs, anti-inflammatory drugs, non-steroidal well as life saving anti-asthma drugs. The company sells many products including the following brands: AptiKid, AptiPro, ColiWell, ConstiVac, HerboHep and OxyHerb, and many other products
In 2007 the company employed more than 8000 people(78 % men and 22% women),it sold 21575.8 Rs Million, the industry is also present in America, Europe (England) and Japan.
For FY09, the Analysis Report show that net sales soared 43% at Rs.3866.64.40% came from domestic and perch from exports. EBITDA Analysis was up 70% at Rs.739.36. It finished the year with a net profit of Rs.501.54, up 23%. During the year, the company buys Rs.231.81 on R&D, which accounts for 6% of the net sales earned and forms about 7% of the total buy incurred during FY09. The trading is good even if one looks at the Q4FY09 trading.
Lupin Ltd has an amazing growth story. If you have anything previous experience about the performances of its shares in the Indian stock market, you are requested to share it here. All your tips, market analysis & suggestions regarding the buying and selling of Lupin Ltd stocks in the trading arena are very welcome in this platform which discusses Indian Companies and their individual & investors’ growth story. However it is highly recommended with trading experts that investing in the shares of this company will undoubtedly provide short term as well as long term benefits for you…
Buy Lupin with a target of Rs 2010 and stop loss of Rs 1785, says Varun Daga, technical analyst, on CNBC Awaaz.
Buy Lupin for good returns in the long term, says Radhika Gupta of Forefront Capital Management on CNBC TV18. The stock is currently trading at Rs 1832.40, down 0.7% on the BSE.
Sell Lupin Futures at Rs 1605 with target of Rs 1585 and stop loss of Rs 1615, says Hemen Kapadia, technical analyst, on CNBC TV18.